Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study

Table 2 Statistical analysis of uPAR expression and associated clinicopathological findings in OSCCs

Variables	No.	UPAr expression n. (%)	Chi-square P <0.05	Mean	Standard deviation	Standard error	Mann Whitney P <0.05	Multiple Comparison Test
Cases	189	74 (39.1)
Age
< 65 years	78	25 (32)	No	39	19.8	14	No
> 65 years	111	49 (44)	0.0989°	55.5	9.192	6.5	0.0854
Sex
Male	143	56 (39.1)	No	71.5	21.92	15.5	No
Female	46	18 (39.1)	1.0000°	23	7.071	5	0.7103
Grading								Dunn's Multiple Comparison Test Difference in rank sum P < 0.05
G1	77	16 (20.8)	Yes	3.052	8.515	0.9703	Yes	G1 vs G2	-16,14	No
G2	68	27 (39.7)	< 0.0001	5.103	12.09	1.466	< 0.0001*	G1 vs G3	-50,00	Yes
G3	44	31 (70.4)		14.77	20.52	3.094		G2 vs G3	-33,87	Yes
Size
< 1.5 cm	48	17 (35.4)	No	3.958	8.124	1.173	No
> 1.5 cm	141	57 (40.4)	0.6092°	7.157	15.28	1.292	0.4607
Recurrence
Positive (+)	85	37 (43.5)	No	42.5	7.778	5.5	No
Negative (-)	104	37 (35.5)	0.296°	52	21.21	15	0.5866
Staging								Dunn's Multiple Comparison Test Difference in rank sum P < 0.05
I	79	25 (31.6)		4.873	13.47	1.516		I vs II	-10,44	No
II	39	16 (41)	No	6.231	11.45	1.833	No	I vs III	-3,138	No
III	25	9 (36)	0.2307	3.760	7.055	1.411	0.0725*	I vs IV	-22,96	No
IV	46	24 (52)		10.39	17.78	2.621		II vs III	7,302	No
								II vs IV	-12,52	No
								III vs IV	-19,82	No

ISSN: 1471-2407